Table 1.
Total | ||
---|---|---|
Histology | N | Percent |
Basal Cell | 25 | 56.8% |
Squamous cell | 17 | 38.6% |
Merckle Cell | 1 | 2.3% |
T-Cell Lymphoma | 1 | 2.3% |
Tumor Stage | N | Percent |
Tis | 1 | 2.3% |
T1 | 39 | 88.6% |
T2 | 1 | 2.3% |
Recurrence | 3 | 6.8% |
Ethnicity | N | Percent |
Caucasian/Non-Hispanic | 35 | 94.6% |
Hispanic | 2 | 5.4% |
Gender | N | Percent |
Male | 27 | 73.0% |
Female | 10 | 27.0% |
Lesion Locations | N | % |
Scalp | 5 | 11.4% |
Face | 14 | 31.8% |
Nose | 16 | 36.4% |
Extremity | 4 | 9.1% |
Ear | 5 | 11.4% |